4//SEC Filing
Manfredi Mark 4
Accession 0000899243-22-004884
CIK 0001835579other
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 6:12 PM ET
Size
5.4 KB
Accession
0000899243-22-004884
Insider Transaction Report
Form 4
Manfredi Mark
DirectorPresident & CEO
Transactions
- Award
Stock Option (Right to Buy)
2022-02-03+238,900→ 238,900 totalExercise: $9.76Exp: 2032-02-03→ Common Stock (238,900 underlying)
Footnotes (1)
- [F1]25% of the shares subject to this option shall vest and become exercisable on January 1, 2023, with the remainder vesting in 36 substantially equal monthly installments thereafter.
Documents
Issuer
Ikena Oncology, Inc.
CIK 0001835579
Entity typeother
Related Parties
1- filerCIK 0001848547
Filing Metadata
- Form type
- 4
- Filed
- Feb 3, 7:00 PM ET
- Accepted
- Feb 4, 6:12 PM ET
- Size
- 5.4 KB